Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort
Multiple Sclerosis and Related Disorders · 2023
DOI: 10.1016/j.msard.2023.104656 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Multiple Sclerosis and Related Disorders, 2023. Verfasst von Haris Majid Rajput und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU), Islamabad, Pakistan. Hauptthemen laut MEDLINE: Neuromyelitis Optica. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The clinical and radiological characteristics of neuromyelitis optica spectrum disorder (NMOSD) from Pakistan is unknown. Our study aimed to describe the clinical and radiological features of NMOSD patients presenting to a Pakistani tertiary care center. MATERIALS AND METHODS: This retrospective, observational study was conducted at the Neurology Department, Pakistan Institute of Medical Sciences between January 2017 and September 2021 (56 months). The study included patients diagnosed with neuromyelitis optica spectrum disorder (NMOSD) according to the 2015 International Panel for NMO Diagnosis (IPND) criteria, with the exclusion of patients under 12 years of age and those who tested positive for Myelin oligodendrocyte glycoprotein (MOG) IgG antibody. The patients were divided into two groups based on clinical presentation and the presence of NMO-IgG antibodies: NMO-IgG positive NMO (Seropositive NMO) and NMO-IgG negative (Seronegative NMO). The clinical features of NMOSD were recorded, and data was analyzed using SPSS version 26.0. RESULTS: Among 204 patients with suspected demyelination, multiple sclerosis was diagnosed in 100 individuals (49.02%), while acute disseminated encephalomyelitis (ADEM), clinically isolated syndrome (CIS), and neuromyelitis optica (NMO) were found in 5 patients each (2.45%, 2.45%, and 17.65%, respectively). Out of 36 patients with NMO, 32 (88.89%) tested positive for NMO-Ab, while the remaining 4 (11.11%) were seronegative for both NMO and anti-MOG Abs. The mean age of NMO-positive patients who tested positive for NMO antibodies was 31.03±10.12 years, compared to 27.95±2.5 years for NMO-negative patients, though this difference was not statistically significant (p>0.05). Females were more commonly affected by NMO, accounting for 72.2% of the NMO-positive group, and there was a significant difference in clinical phenotypes between the two groups (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU), Islamabad, Pakistan.
- Department of Neurology, Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU), Islamabad, Pakistan. Electronic address: drhassaanshafqat2011@gmail.com.
Zitieren
APA
Rajput, H. M., Hassan, M., & Badshah, M. (2023). Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2023.104656
Vancouver
Rajput HM, Hassan M, Badshah M. Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort. Multiple Sclerosis and Related Disorders. 2023. doi:10.1016/j.msard.2023.104656
BibTeX
@article{Rajput2023,
author = {Rajput, Haris Majid and Hassan, Muhammad and Badshah, Mazhar},
title = {Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort},
journal = {Multiple Sclerosis and Related Disorders},
year = {2023},
doi = {10.1016/j.msard.2023.104656}
}
EUVIMED